SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

INTRODUCTION: Based on post-marketing surveillance, concern has been raised that sodium–glucose cotransporter 2 inhibitors (SGLT2i) may increase the risk of necrotizing fasciitis of the perineum (Fournier’s gangrene, FG). As a result of the low incidence of FG, data from clinical trials may be insuf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tongtong, Patel, Shrita M., Hickman, Anne, Liu, Xinyue, Jones, Philip LStJ, Gantz, Ira, Koro, Carol E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048884/
https://www.ncbi.nlm.nih.gov/pubmed/32052281
http://dx.doi.org/10.1007/s13300-020-00771-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048884/
https://www.ncbi.nlm.nih.gov/pubmed/32052281
http://dx.doi.org/10.1007/s13300-020-00771-8

Ejemplares similares